Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Ascentage Pharma logo

Ascentage Pharma

Recent Finacing

Equity

Recent Raise

$75M

Ascentage Pharma is a clinical-stage biopharmaceutical developing small-molecule apoptosis-targeted therapies, advancing Bcl-2/Bcl-xL, IAP, MDM2–p53 and next-gen kinase inhibitor programs across US, China.

Founded 2009
Jiangsu, China
101-250
Publicly Traded
ascentagepharma.com

Highlights

Focus Areas

Biopharma
Biotechnology
Medical
Pharmaceutical

Recent Investors

Efung Capital logo
YuanMing Capital logo
Oriza Ventures logo
CCB International logo
Teng Yue Partners logo
H
Y
元禾控股 logo
ArrowMark Partners logo
C
Takeda logo
Hidragon Capital logo

Financials

$312.6M

Total Raised

4

Funding rounds

17

Investors


Team

Upgrade to view the team

See the team members at Ascentage Pharma.